Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Holistic Bio is a South Korean biotechnology company focused on the development and manufacturing of clinically proven health products and nutraceuticals derived from natural sources. The company specializes in the research of Panax ginseng berry extracts (GBE) and grain-fermented enzymes to address age-related conditions such as sarcopenia and muscle deterioration. Their research has demonstrated that specific mixtures of ginseng berry extract and whey protein hydrolysate can modulate muscle protein turnover through the PI3K/Akt/mTOR pathway and reduce myostatin levels. Holistic Bio aims to lead a "Holistic Food Revolution" by materializing "holistic beauty" and longevity through innovative biotechnological applications in functional foods. The company operates a manufacturing facility and engages in academic collaborations to validate the efficacy of its bioactive compounds.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Holistic Bio.